REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro de Neuroestimulacion Neuroptima S.A.S. (Ecuador)

Main Activities: Pharmacies and Drug Stores
Full name: Centro de Neuroestimulacion Neuroptima S.A.S. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Centro de Neuroestimulacion Neuroptima S.A.S. is a company based in Ecuador, with its head office in Loja. It operates in the Pharmacies and Drug Stores industry. It was established on July 20, 2023. 2 (2024) employees currently work for Centro de Neuroestimulacion Neuroptima S.A.S.. There was a net sales revenue drop of 6.1% reported in Centro de Neuroestimulacion Neuroptima S.A.S.’s latest financial highlights for 2025. During that time, Centro de Neuroestimulacion Neuroptima S.A.S.’s total assets grew by 35.5%.

Headquarters
Av. Cuxibamba, 07-33
Loja; Loja;

Contact Details: Purchase the Centro de Neuroestimulacion Neuroptima S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Centro de Neuroestimulacion Neuroptima S.A.S. report to view the information.
Registered Capital:
Purchase the Centro de Neuroestimulacion Neuroptima S.A.S. report to view the information.
Financial Auditors:
Purchase the Centro de Neuroestimulacion Neuroptima S.A.S. report to view the information.
Incorporation Date:
July 20, 2023
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Centro de Neuroestimulacion Neuroptima S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-6.1%
Total Operating Revenue
-6.1%
Operating Profit
1613.04%
EBITDA
1613.04%
Total Assets
35.5%
Total Equity
35.5%
Operating Profit Margin
25.96%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?